Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial
Work
Year: 2015
Type: article
Abstract: Randomised placebo-controlled trials have shown that daily oral pre-exposure prophylaxis (PrEP) with tenofovir-emtricitabine reduces the risk of HIV infection. However, this benefit could be counterac... more
Source: The Lancet
Institutions MRC Clinical Trials Unit at UCL, University College London, Chelsea and Westminster Hospital NHS Foundation Trust, Public Health England, Central and North West London NHS Foundation Trust +17 more
Cites: 24
Cited by: 1,721
Related to: 10
FWCI: 109.6
Citation percentile (by year/subfield): 99.99
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: hybrid
APC paid (est): $5,968